These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases. Ba C; Wang H; Jiang C; Shi X; Jin J; Fang Q BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413119 [TBL] [Abstract][Full Text] [Related]
11. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study. Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease. Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978 [TBL] [Abstract][Full Text] [Related]
13. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis. Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910 [TBL] [Abstract][Full Text] [Related]
14. Acute exacerbation of interstitial lung disease after procedures. Amundson WH; Racila E; Allen T; Dincer HE; Tomic R; Bhargava M; Perlman DM; Kim HJ Respir Med; 2019 Apr; 150():30-37. PubMed ID: 30961948 [TBL] [Abstract][Full Text] [Related]
17. Development of tools to facilitate palliative and supportive care referral for patients with idiopathic pulmonary fibrosis. Sharp C; Lamb H; Jordan N; Edwards A; Gunary R; Meek P; Millar AB; Kendall C; Adamali H BMJ Support Palliat Care; 2018 Sep; 8(3):340-346. PubMed ID: 28667087 [TBL] [Abstract][Full Text] [Related]
18. Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis. Kondoh Y; Cottin V; Brown KK Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954766 [TBL] [Abstract][Full Text] [Related]
19. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer. Enomoto Y; Inui N; Kato T; Baba T; Karayama M; Nakamura Y; Ogura T; Suda T Lung Cancer; 2016 Jun; 96():63-7. PubMed ID: 27133752 [TBL] [Abstract][Full Text] [Related]
20. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases. Salonen J; Purokivi M; Bloigu R; Kaarteenaho R BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]